stockrowPulse Biosciences, Inc (PLSE) vs Warby Parker Inc. (WRBY)
- Pulse Biosciences, Inc PLSE 53.15 −6.85%
- Warby Parker Inc. WRBY 26.05 +22.36%
Pulse Biosciences, Inc and Warby Parker Inc. are both Medical Instruments & Supplies companies. Pulse Biosciences, Inc is the larger, with a market value of $3.9B against $3.2B — 1.2× the size. Pulse Biosciences, Inc has negative trailing earnings, so its P/E is not meaningful; Warby Parker Inc. trades at 434×. Pulse Biosciences, Inc grew revenue faster over the last twelve months: 90.1% against 9.89%. Warby Parker Inc. has the higher net margin (0.80% vs −5,609.4%) and the higher return on invested capital (0.83% vs −37.0%). Across the 16 metrics below, Warby Parker Inc. leads on 14 and Pulse Biosciences, Inc on 2.
Valuation
Profitability
| Metric | PLSE | WRBY | Medical Instruments & Supplies median |
|---|---|---|---|
| Gross margin | 26.77% | 54.75% | 53.60% |
| Operating margin | (5,821.08%) | 0.16% | 1.97% |
| Net margin | (5,609.44%) | 0.80% | 0.00% |
| Free cash flow margin | (14,462.52%) | 2.28% | 2.36% |
| Return on equity | (60.67%) | 1.93% | 0.00% |
| Return on assets | (54.01%) | 1.00% | 0.00% |
| Return on invested capital | (37.01%) | 0.83% | 0.13% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack